SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-089653
Filing Date
2024-04-08
Accepted
2024-04-08 16:30:56
Documents
19
Period of Report
2024-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d808044d8k.htm   iXBRL 8-K 28259
2 EX-99.1 d808044dex991.htm EX-99.1 22386
3 EX-99.2 d808044dex992.htm EX-99.2 14488
4 EX-99.3 d808044dex993.htm EX-99.3 15853
8 GRAPHIC g808044g05v88.jpg GRAPHIC 456385
9 GRAPHIC g808044g06k88.jpg GRAPHIC 467961
10 GRAPHIC g808044snap1.jpg GRAPHIC 4571
  Complete submission text file 0001193125-24-089653.txt   1509393

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pstx-20240408.xsd EX-101.SCH 2838
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20240408_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20240408_pre.xml EX-101.PRE 11699
22 EXTRACTED XBRL INSTANCE DOCUMENT d808044d8k_htm.xml XML 3777
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 24829983
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)